We are live on ! Find out more
KA

Kovack Advisors Portfolio holdings

AUM $2.08B
1-Year Est. Return 38.95%
This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+38.95%
3 Year Est. Return
+118.27%
5 Year Est. Return
+142.08%
10 Year Est. Return
+472.03%
AUM
$342M
AUM Growth
-$45.8M
Cap. Flow
+$8.6M
Cap. Flow %
2.52%
Top 10 Hldgs %
23.7%
Holding
520
New
53
Increased
186
Reduced
147
Closed
96

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.87%
2 Technology 9.98%
3 Consumer Discretionary 8.1%
4 Healthcare 6.19%
5 Communication Services 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
126
PayPal
PYPL
$52.6B
$675K 0.2%
8,023
-1,130
-12% -$94.1K
CELG
127
DELISTED
Celgene Corp
CELG
$665K 0.19%
10,379
-2,856
-22% -$211K
XLY icon
128
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.8B
$644K 0.19%
13,018
-1,540
-11% -$81.4K
VPU
129
Vanguard Utilities ETF
VPU
$8.35B
$641K 0.19%
+5,440
New +$659K
IJH icon
130
iShares Core S&P Mid-Cap ETF
IJH
$126B
$636K 0.19%
19,140
+3,580
+23% +$131K
VWO icon
131
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$633K 0.19%
16,608
+1,972
+13% +$76.4K
COP icon
132
ConocoPhillips
COP
$156B
$628K 0.18%
10,080
+279
+3% +$19K
YUM icon
133
Yum! Brands
YUM
$41.1B
$626K 0.18%
6,809
-415
-6% -$37.1K
QUAL icon
134
iShares MSCI USA Quality Factor ETF
QUAL
$48B
$624K 0.18%
8,128
-895
-10% -$74.3K
BUD icon
135
AB InBev
BUD
$156B
$622K 0.18%
9,454
+726
+8% +$55.5K
BIV icon
136
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$621K 0.18%
7,641
+274
+4% +$21.9K
OXY icon
137
Occidental Petroleum
OXY
$59.1B
$603K 0.18%
9,819
+3,501
+55% +$246K
IBM icon
138
IBM
IBM
$225B
$599K 0.18%
5,513
+1,425
+35% +$171K
LLY icon
139
Eli Lilly
LLY
$1.05T
$598K 0.17%
5,166
+896
+21% +$100K
KRE icon
140
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
$597K 0.17%
12,760
-1,860
-13% -$99.4K
SDY icon
141
State Street SPDR S&P Dividend ETF
SDY
$22B
$593K 0.17%
6,627
-491
-7% -$46.3K
BMY icon
142
Bristol-Myers Squibb
BMY
$137B
$583K 0.17%
11,218
+325
+3% +$17.5K
FBT icon
143
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.97B
$582K 0.17%
4,683
-2,300
-33% -$315K
TMO icon
144
Thermo Fisher Scientific
TMO
$233B
$573K 0.17%
2,558
+696
+37% +$163K
CWB icon
145
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.68B
$564K 0.16%
12,062
+10
+0.1% +$503
IJT icon
146
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.18B
$562K 0.16%
6,964
-402
-5% -$35.8K
IXJ icon
147
iShares Global Healthcare ETF
IXJ
$4.32B
$562K 0.16%
9,927
HUM icon
148
Humana
HUM
$47.1B
$561K 0.16%
1,958
+64
+3% +$20.3K
RGLD icon
149
Royal Gold
RGLD
$22.8B
$557K 0.16%
6,500
+3,500
+117% +$269K
MIC
150
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$556K 0.16%
15,195
-360
-2% -$14.4K

Similar funds

Kovack Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Kovack Advisors held 520 positions worth $342M, down 12% from $388M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Kovack Advisors's Q4 2018 filing shows 53 new, 186 increased, 147 reduced and 96 closed positions. Its largest new stake was iShares US Healthcare Providers ETF: 23,900 shares worth $790K. The largest sale was Sherwin-Williams, an estimated $1.11M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 48% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Kovack Advisors's largest Q4 2018 buy was iShares US Healthcare Providers ETF: 23,900 shares worth $790K.
  • Kovack Advisors added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2018, an estimated $4.86M increase.
  • Kovack Advisors's biggest Q4 2018 reduction was Vanguard Total International Stock ETF, cutting an estimated $614K.
  • Kovack Advisors fully exited Sherwin-Williams in Q4 2018, selling an estimated $1.11M.
  • Kovack Advisors's ten largest holdings make up 24% of its $342M portfolio in Q4 2018.
  • Kovack Advisors opened 53 new positions and closed 96 in Q4 2018.
  • Kovack Advisors's portfolio value fell 12% quarter-over-quarter to $342M.

Based on Kovack Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.